- Report
- February 2024
- 126 Pages
Global
From €2886EUR$2,990USD£2,476GBP
- Report
- May 2023
- 100 Pages
Global
From €5743EUR$5,950USD£4,926GBP
- Report
- April 2024
- 354 Pages
Global
From €5405EUR$5,600USD£4,637GBP
- Report
- February 2021
- 342 Pages
Global
From €3619EUR$3,750USD£3,105GBP
- Report
- April 2023
- 110 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- April 2023
- 147 Pages
Global
From €5790EUR$5,999USD£4,967GBP
The Oral Iron market within the context of Hematological Drugs is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat anemia and other blood-related disorders. Oral Iron is a type of drug used to treat iron deficiency anemia, a condition in which the body does not have enough healthy red blood cells due to a lack of iron. Oral Iron is taken orally, usually in the form of a pill or liquid, and is absorbed into the bloodstream to replenish iron levels. Oral Iron is often prescribed in combination with other drugs, such as Vitamin B12 and folic acid, to treat anemia.
Some companies in the Oral Iron market include GlaxoSmithKline, Pfizer, Merck, and Sanofi. Show Less Read more